Based on the above experimental results, CCK-8 was used to test PANC-1, HepG2, and A549 tumor cells treated with NK cells, Anti-MICB-CAR-NK cells, and Anti-MICB-CAR-NK supernatant + NK cells for 24 h. Here, MICB is linked to neoplasm.